Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 2.4/5
Mesoblast Ltd

Mesoblast Ltd (MSB AU)

66
Analysis
Health CareAustralia
Mesoblast Limited provides biomedical services. The Company develops drugs for cardiovascular diseases, oncology, hematology, and spine orthopedic disorders treatment. Mesoblast conducts its business worldwide.
more
bullishCIMIC Group Ltd
23 Feb 2022 15:33

CIMIC (CIM AU) Replacement in ASX200

CIMIC's takeover by Hochtief triggers another index change in ASX200 - likely sometime in April. This brings forward the first intra-quarter ASX200...

Logo
354 Views
Share
bullishNongfu Spring
19 Feb 2022 20:23

Index Rebalance & ETF Flow Recap: HSI, HSCEI, HSTECH, HSCI, S&P/ASX, SET50, LIC, SBI Sumishin, Crown

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
589 Views
Share
19 Feb 2022 14:40

The Weird Ways of the Aventus/HomeCo Daily Needs Index Rebalances (ASX200)

Aventus and Homeco Daily Needs now have the last doc/approval needed to proceed with their merger. The last day of trading for Aventus is 23 Feb....

Logo
411 Views
Share
bullishMesoblast Ltd
19 Feb 2022 08:54

Mesoblast (MSB AU): Preparing for Re-Submission of Biologics License Application for Ryoncil

Mesoblast is preparing for biologics license application for two of its pipeline candidates. The company believes it has generated substantial new...

Logo
381 Views
Share
18 Feb 2022 12:12

S&P/​​ASX Indices: Quiddity Leaderboard for March 2022 Rebalance (Final)

A final look at the leading candidates who could become Adds/Deletes during the March 2022 Rebalance and other potential irregular changes.

Share
x